UNC Health Provider Ushers In First FDA-Approved Medication For Eosinophilic Esophagitis
December 22, 2022
December 22, 2022
CHAPEL HILL, North Carolina, Dec. 22 (TNSjou) -- The University of North Carolina School of Medicine issued the following news release:
* * *
Evan Dellon, MD, MPH, a professor in the Department of Medicine and director of the Center for Esophageal Diseases and Swallowing, co-leads effort to approve an allergy drug, dupilumab, for the treatment in adults and adolescents with eosinophilic esophagitis.
* * *
Eosinophilic esophagitis (EoE) is an al . . .
* * *
Evan Dellon, MD, MPH, a professor in the Department of Medicine and director of the Center for Esophageal Diseases and Swallowing, co-leads effort to approve an allergy drug, dupilumab, for the treatment in adults and adolescents with eosinophilic esophagitis.
* * *
Eosinophilic esophagitis (EoE) is an al . . .